Drawing for IMMUNOSEQ

USPTO serial 86213681

IMMUNOSEQ

Reviewed by CopyMark Law Group

Reg. 4706763Status 710
Filing date
Status date
Registration date
Mar 24, 2015
Examiner
STOIDES, KATHERINE
Law office
TMEG LAW OFFICE 101

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with IMMUNOSEQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Hoang-chi Truong

Hoang-chi Truong Patent Law Works LLP310 East 4500 South, Suite 400Salt Lake City, UT 84107UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genome amplification; Genotyping services for research or analysis purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research in the field of genetics and genetic engineeringSECTION 8 - CANCELLEDSep 8, 2009

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2025CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Mar 24, 2024REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jul 27, 2021NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 27, 2021C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 27, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 24, 2021E815TEAS SECTION 8 & 15 RECEIVED—
Mar 24, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 13, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 24, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 6, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 6, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 17, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 4, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 29, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 20, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 20, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 19, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 28, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 28, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 11, 2014CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Jun 11, 2014ALIEASSIGNED TO LIE—
Jun 11, 2014GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 11, 2014GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 11, 2014CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jun 10, 2014DOCKASSIGNED TO EXAMINER—
Mar 21, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Mar 20, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance